At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 2,331 enrolled
Drug / intervention
Supervised Exercise Training Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)
In Brief
A Phase 3 clinical trial evaluating Supervised Exercise Training Program for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 2,331 participants across 80 sites in 3 countries.
Detailed Summary
The purpose of this study is to determine the long-term safety and effectiveness of exercise training for individuals with congestive heart failure (CHF).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, France, United States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2002
Enrollment StartApr 2003
Primary CompletionJul 2008
TodayJul 2026
First PostedOct 4, 2002
Enrollment StartApr 1, 2003
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 23.7 years ago
Interventions
Supervised Exercise Training Programbehavioral
Exercise 30 minutes minimum three times per week.